35 related articles for article (PubMed ID: 9158102)
1. Acquisition of immune function during the development of the Langerhans cell network in neonatal mice.
Dewar AL; Doherty KV; Woods GM; Lyons AB; Muller HK
Immunology; 2001 May; 103(1):61-9. PubMed ID: 11380693
[TBL] [Abstract][Full Text] [Related]
2. Langerhans' cells in the murine oral mucosa in the inductive phase of delayed type hypersensitivity with 1-chloro-2, 4-dinitrobenzene.
Okamura T; Morimoto M; Yamane G; Takahashi S
Clin Exp Immunol; 2003 Nov; 134(2):188-94. PubMed ID: 14616776
[TBL] [Abstract][Full Text] [Related]
3. DEC-205lo Langerinlo neonatal Langerhans' cells preferentially utilize a wortmannin-sensitive, fluid-phase pathway to internalize exogenous antigen.
Bellette BM; Woods GM; Wozniak T; Doherty KV; Muller HK
Immunology; 2003 Dec; 110(4):466-73. PubMed ID: 14632644
[TBL] [Abstract][Full Text] [Related]
4. Description and management of patients with anal fissure: insights on Italian primary care setting coming from real-world data.
Gallo G; Pegoraro V; Trompetto M
Updates Surg; 2024 May; ():. PubMed ID: 38796820
[TBL] [Abstract][Full Text] [Related]
5. A calcium channel blocker nifedipine distorts the effects of nano-zinc oxide on metal metabolism in the marsh frog
Falfushynska H; Gnatyshyna L; Horyn O; Shulgai A; Stoliar O
Saudi J Biol Sci; 2019 Mar; 26(3):481-489. PubMed ID: 30899162
[TBL] [Abstract][Full Text] [Related]
6. Hypertension: a new treatment for an old disease? Targeting the immune system.
Bomfim GF; Cau SBA; Bruno AS; Fedoce AG; Carneiro FS
Br J Pharmacol; 2019 Jun; 176(12):2028-2048. PubMed ID: 29969833
[TBL] [Abstract][Full Text] [Related]
7. Computational analysis of high-throughput flow cytometry data.
Robinson JP; Rajwa B; Patsekin V; Davisson VJ
Expert Opin Drug Discov; 2012 Aug; 7(8):679-93. PubMed ID: 22708834
[TBL] [Abstract][Full Text] [Related]
8. Topical 0.5% nifedipine vs. lateral internal sphincterotomy for the treatment of chronic anal fissure: long-term follow-up.
Katsinelos P; Papaziogas B; Koutelidakis I; Paroutoglou G; Dimiropoulos S; Souparis A; Atmatzidis K
Int J Colorectal Dis; 2006 Mar; 21(2):179-83. PubMed ID: 16091912
[TBL] [Abstract][Full Text] [Related]
9. The role of interleukin-16 in murine contact hypersensitivity.
Masuda K; Katoh N; Soga F; Kishimoto S
Clin Exp Immunol; 2005 May; 140(2):213-9. PubMed ID: 15807844
[TBL] [Abstract][Full Text] [Related]
10. Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells.
Teunissen MB
Histochem J; 1992 Oct; 24(10):697-716. PubMed ID: 1428996
[TBL] [Abstract][Full Text] [Related]
11. Accessory and adhesion molecules expressed on murine epidermal Langerhans cells and the modulation by cytokines.
Nakamura K; Tamaki K
J Dermatol Sci; 1998 May; 20(1):14-20. PubMed ID: 10342744
[TBL] [Abstract][Full Text] [Related]
12. Calcium channel blockers suppress the contact hypersensitivity reaction (CHR) by inhibiting antigen transport and presentation by epidermal Langerhans cells in mice.
Katoh N; Hirano S; Kishimoto S; Yasuno H
Clin Exp Immunol; 1997 May; 108(2):302-8. PubMed ID: 9158102
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of cutaneous immune responses by ATP gamma S: purinergic agonists define a novel class of immunologic adjuvants.
Granstein RD; Ding W; Huang J; Holzer A; Gallo RL; Di Nardo A; Wagner JA
J Immunol; 2005 Jun; 174(12):7725-31. PubMed ID: 15944274
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
Ozawa H; Aiba S; Nakagawa ; Tagami H
Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
[TBL] [Abstract][Full Text] [Related]
15. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
